A5001873276- Helicobacter pylori-related gastroenterology studies
- Gastric Cancer Management and Outcomes
- Gastroesophageal reflux and treatments
- Veterinary medicine and infectious diseases
- Colorectal Cancer Screening and Detection
- Clostridium difficile and Clostridium perfringens research
- Gastrointestinal disorders and treatments
- Colorectal Cancer Treatments and Studies
- Mycobacterium research and diagnosis
- Intestinal and Peritoneal Adhesions
Trinity College Dublin
2009-2025
Aim: To evaluate the prescriptions patterns, effectiveness, and safety of adding probiotics to Helicobacter pylori eradication therapy, in Europe. Design: International, prospective, non-interventional registry clinical practice European gastroenterologists. Data were collected quality reviewed until March 2021 at AEG-REDCap. The effectiveness was evaluated by modified intention-to-treat analysis, differentiating geographic areas. Adverse events (AE) categorized as mild, moderate, severe....
Eradication rates for the standard first-line triple therapy Helicobacter pylori infection have decreased in recent years. Sequential has been suggested as an alternative. The efficacy of sequential not assessed to date Irish population.The aim this study was compare with H. eradication.A prospective randomized-controlled carried out. Treatment-naive pylori-infected patients were randomized receive either or therapy.In all, 87 eligible recruited into study, one whom dropped Fifty-one per...
Background. As part of an observational multicenter prospective study European Registry on the management Helicobacter pylori infection, conducted initiative H. and Microbiota Study Group, compliance clinical practice in patients with infection Kazan guidelines was assessed. Materials methods. The data 437 included into register by sites 20132019 were analyzed. methods used for initial diagnosis eradication control evaluated. frequency various therapy regimens prescription analyzed 379...
Gastric cancer is the third most common cause of cancer-related death globally. The highest incidence encountered in Asia, followed by Europe which has second worldwide. In Europe, gastric typically diagnosed at an advanced stage, with estimated five-year survival rate 24%, compared to 59% Japan. This disparity largely attributed significant role screening Given expected rise absolute numbers cases, there been a demand for programmes high-intermediate risk countries, advocated International...
Colorectal cancer remains a significant cause of morbidity and mortality throughout the world. The incidence colorectal is nearly four-fold higher in more-developed as compared with less-developed regions At present an early detection crucial step determining therapeutic outcomes. Screening programmes have been introduced effort to detect at stage or precancerous colonic polyp stage. These should be used by health professionals opportunity educate public regarding use chemoprevention cancer,...